论文部分内容阅读
研究背景:尽管随机试验已经表明环氧合酶(COX-2)抑制剂可增加心血管风险,但对非选择性非甾体类抗炎药(NSAIDs)和对乙酰氨基酚的研究结果不一致。方法和结果:我们从1990年始,对基线70971名妇女(年龄44~69岁,排除已知心血管疾病和癌症者) 进行了为期12年的前瞻性队列研究,观察NSAIDs和对乙酰氨基酚对心血管事件风险的影响。对这些人选
Background: Although randomized trials have shown that cyclooxygenase (COX-2) inhibitors may increase cardiovascular risk, the results of nonselective NSAIDs and acetaminophen studies are inconsistent. METHODS AND RESULTS: From the beginning of 1990, we conducted a prospective cohort study of 70,971 women (aged 44-69 years with exclusion of known cardiovascular disease and cancer) of baseline for a period of 12 years. We investigated the effects of NSAIDs and acetaminophen on heart Impact of Vascular Event Risk. For these candidates